Correlative Analysis of the Expression of IL-10 and Ki-67 in Human Cervical Cancer and Cervical Intraepithelial Neoplasias and Human Papillomavirus Infection

Overview

Journal Oncol Lett

Specialty Oncology

Date 2018 Dec 15

PMID 30546456

Citations 3

Authors

Zhihong Min

Xiaowen Pu

Zhengrong Gu

Affiliations

Soon will be listed here.

Abstract

This study investigated the expression of IL-10 and Ki-67 in human cervical cancer and cervical intraepithelial neoplasia (CIN) and the correlation with human papillomavirus infection. A total of 110 patients with cervical lesions undergoing surgical treatment in Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine from 2016 to 2017 were selected. Those patients included 36 cases of cervical cancer and 74 cases of CIN. At the same time, 30 cases of chronic cervicitis were selected as the control group. RT-qPCR was used to detect the expression of IL-10 and Ki-67 in cervical tissue. PCR was used to detect HPV infection in cervical tissue. The expression levels of IL-10 and Ki-67 in the cervical cancer and CIN groups were higher than those in the control group. Moreover, the expression levels of IL-10 and Ki-67 in the cervical cancer and CIN II-III groups were higher than those in the CIN I group (P<0.05). In addition, the expression levels of IL-10 and Ki-67 in the cervical cancer group were significantly higher than those in the CIN II-III group. Furthermore, the expression levels of IL-10 and Ki-67 were positively correlated with HPV infection (r=0.783 or 0.712, P<0.05). Finally, the expression levels of IL-10 and Ki-67, and HPV infection in the cervical lesions studied were significantly different. Therefore, combined detection of IL-10, Ki-67 and HPV infection can improve the diagnosis of CIN and early cervical cancer.

Citing Articles

The analysis of HPV integration sites based on nanopore sequencing and the profiling changes along the course of photodynamic therapy.

Li X, Wei X, Liu X, Wang N, Xu F, Liu X BMC Cancer. 2023; 23(1):1052.

PMID: 37914994 PMC: 10621124. DOI: 10.1186/s12885-023-11538-2.

Preliminary Study on the Expression of Testin, p16 and Ki-67 in the Cervical Intraepithelial Neoplasia.

Popiel A, Piotrowska A, Sputa-Grzegrzolka P, Smolarz B, Romanowicz H, Dziegiel P Biomedicines. 2021; 9(8).

PMID: 34440214 PMC: 8391355. DOI: 10.3390/biomedicines9081010.

IL-10 c.-592C>A (rs1800872) polymorphism is associated with cervical cancer.

Lombardi Pereira A, Trugilo K, Okuyama N, Sena M, Couto-Filho J, Watanabe M J Cancer Res Clin Oncol. 2020; 146(8):1971-1978.

PMID: 32447484 DOI: 10.1007/s00432-020-03256-0.

References

Munoz N, Hernandez-Suarez G, Mendez F, Molano M, Posso H, Moreno V . Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. Br J Cancer. 2009; 100(7):1184-90. PMC: 2669994. DOI: 10.1038/sj.bjc.6604972. View

Zhang M, Liu Y, Liu S, Zhang B, Si J, Xu X . [Assay and L1 gene sequence analysis of human papillomavirus type 6 and 11 in condylomata acuminata]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003; 22(5):463-6. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Pedroza-Torres A, Campos-Parra A, Millan-Catalan O, Loissell-Baltazar Y, Zamudio-Meza H, Cantu de Leon D . MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer. Oncol Rep. 2018; 39(3):1532-1540. DOI: 10.3892/or.2018.6219. View

Ekalaksananan T, Malat P, Pientong C, Kongyingyoes B, Chumworathayi B, Kleebkaow P . Local cervical immunity in women with low-grade squamous intraepithelial lesions and immune responses after abrasion. Asian Pac J Cancer Prev. 2014; 15(10):4197-201. DOI: 10.7314/apjcp.2014.15.10.4197. View

Araujo-Neto A, Ferreira-Fernandes H, Amaral C, Santos L, Freitas A, Silva-Neto J . Lack of detection of human papillomavirus DNA in prostate carcinomas in patients from northeastern Brazil. Genet Mol Biol. 2016; 39(1):24-9. PMC: 4807381. DOI: 10.1590/1678-4685-GMB-2015-0122. View

Amador-Molina A, Hernandez-Valencia J, Lamoyi E, Contreras-Paredes A, Lizano M . Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response. Viruses. 2013; 5(11):2624-42. PMC: 3856406. DOI: 10.3390/v5112624. View

Jimenez-Wences H, Martinez-Carrillo D, Peralta-Zaragoza O, Campos-Viguri G, Hernandez-Sotelo D, Jimenez-Lopez M . Methylation and expression of miRNAs in precancerous lesions and cervical cancer with HPV16 infection. Oncol Rep. 2016; 35(4):2297-305. DOI: 10.3892/or.2016.4583. View

Vuitton D, Azizi A, Richou C, Vuitton L, Blagosklonov O, Delabrousse E . Current interventional strategy for the treatment of hepatic alveolar echinococcosis. Expert Rev Anti Infect Ther. 2016; 14(12):1179-1194. DOI: 10.1080/14787210.2016.1240030. View

10.

Cilfone N, Ford C, Marino S, Mattila J, Gideon H, Flynn J . Computational modeling predicts IL-10 control of lesion sterilization by balancing early host immunity-mediated antimicrobial responses with caseation during mycobacterium tuberculosis infection. J Immunol. 2014; 194(2):664-77. PMC: 4283220. DOI: 10.4049/jimmunol.1400734. View

11.

Wagner M, Bennetts L, Patel H, Welner S, de Sanjose S, Weiss T . Global availability of data on HPV genotype-distribution in cervical, vulvar and vaginal disease and genotype-specific prevalence and incidence of HPV infection in females. Infect Agent Cancer. 2015; 10:13. PMC: 4435914. DOI: 10.1186/s13027-015-0008-y. View

12.

Bergner S, Halec G, Schmitt M, Aubin F, Alonso A, Auvinen E . Individual and Complementary Effects of Human Papillomavirus Oncogenes on Epithelial Cell Proliferation and Differentiation. Cells Tissues Organs. 2015; 201(2):97-108. DOI: 10.1159/000441716. View

13.

Chung E, Liu J, Zhang Y, Ma X . Differential expression in lupus-associated IL-10 promoter single-nucleotide polymorphisms is mediated by poly(ADP-ribose) polymerase-1. Genes Immun. 2007; 8(7):577-89. DOI: 10.1038/sj.gene.6364420. View

14.

Barbisan G, Perez L, Contreras A, Golijow C . TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk. Tumour Biol. 2012; 33(5):1549-56. DOI: 10.1007/s13277-012-0408-1. View

15.

Vidal J, Felix S, Chaves C, Patury P, Franco V, de Morais E . Genetic diversity of HPV16 and HPV18 in Brazilian patients with invasive cervical cancer. J Med Virol. 2015; 88(7):1279-87. DOI: 10.1002/jmv.24458. View

16.

Hildesheim A, Gonzalez P, Kreimer A, Wacholder S, Schussler J, Rodriguez A . Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment. Am J Obstet Gynecol. 2016; 215(2):212.e1-212.e15. PMC: 4967374. DOI: 10.1016/j.ajog.2016.02.021. View

17.

Ho C, Chien T, Huang S, Wu C, Shih B, Chang S . Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol Oncol. 2004; 93(2):458-64. DOI: 10.1016/j.ygyno.2004.01.026. View

18.

Karanikas V, Zamanakou M, Kerenidi T, Dahabreh J, Hevas A, Nakou M . Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer. Cancer Biol Ther. 2007; 6(8):1258-62. DOI: 10.4161/cbt.6.8.4446. View

19.

Landoni F, Colombo A, Milani R, Placa F, Zanagnolo V, Mangioni C . Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update. J Gynecol Oncol. 2017; 28(3):e34. PMC: 5391393. DOI: 10.3802/jgo.2017.28.e34. View

20.

Leto M, Santos Junior G, Porro A, Tomimori J . Human papillomavirus infection: etiopathogenesis, molecular biology and clinical manifestations. An Bras Dermatol. 2011; 86(2):306-17. DOI: 10.1590/s0365-05962011000200014. View